Company intelligence / Profile preview

Tagworks Pharmaceuticals

Nijmegen, Gelderland, Netherlandstagworkspharma.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Tagworks’ lead candidate TGW101, a first-in-class ADC targeting TAG72 with an MMAE payload using Click-to-Release linker chemistry, has entered Phase I trials to assess safety/tolerability and determine dosing. Preclinical data showed favorable safety and durable anti-tumor responses. The company’s approach enables targeted payload activation at the tumor site without requiring internalization by cancer cells—a limitation of conventional ADCs—potentially expanding the treatable patient population.

Therapeutic areas
Oncology
Modalities
Antibody-drug conjugates (ADCs)RadiopharmaceuticalsSmall molecules (platform compatible)Peptides (platform compatible)Immunomodulators
Industry
Biotech
02

Drug pipeline

8 assets

TGW101

1

7 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Tagworks Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tagworks Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call